Detalhe da pesquisa
1.
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE Trials.
Retina
; 37(6): 1126-1133, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27668928
2.
Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States.
Ophthalmology
; 122(5): 982-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670501
3.
Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.
Ophthalmology
; 121(12): 2461-72, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25148789
4.
Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
Ophthalmology
; 120(1): 160-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23009891
5.
Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.
Ophthalmology
; 119(10): 2108-18, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22817833
6.
Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
Clin Breast Cancer
; 22(8): 781-791, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220724
7.
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR.
Ophthalmology
; 117(4): 747-56.e4, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20189654
8.
Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema.
Clin Ophthalmol
; 14: 1249-1259, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32440092
9.
Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
Pharmacoeconomics
; 37(8): 1071, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089966
10.
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
Pharmacoeconomics
; 36(12): 1463-1473, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194623
11.
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.
Arch Ophthalmol
; 125(11): 1460-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17998507
12.
Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
JAMA Ophthalmol
; 131(7): 851-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23699977
13.
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Invest Ophthalmol Vis Sci
; 52(6): 3354-9, 2011 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282568
14.
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
Arch Ophthalmol
; 127(1): 13-21, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139332
15.
Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration.
Invest Ophthalmol Vis Sci
; 53(13): 7950, 2012 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23208790
16.
Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.
Ann Allergy Asthma Immunol
; 95(3): 247-53, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16200815
17.
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
Ann Allergy Asthma Immunol
; 92(1): 32-9, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14756462